These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 8891298)

  • 1. The sigma ligand rimcazole activates noradrenergic neurons projecting to the paraventricular nucleus and increases corticosterone secretion in rats.
    Eaton MJ; Lookingland KJ; Moore KE
    Brain Res; 1996 Sep; 733(2):162-6. PubMed ID: 8891298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The sigma receptor ligand rimcazole alters secretion of prolactin and alpha-melanocyte stimulating hormone by dopaminergic and non-dopaminergic mechanisms.
    Eaton MJ; Lookingland KJ; Moore KE
    Eur J Pharmacol; 1996 Mar; 299(1-3):171-7. PubMed ID: 8901020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noradrenergic and dopaminergic activity in the hypothalamic paraventricular nucleus after naloxone-induced morphine withdrawal.
    Fuertes G; Laorden ML; Milanés MV
    Neuroendocrinology; 2000 Jan; 71(1):60-7. PubMed ID: 10644900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3-Methoxy-4-hydroxyphenylethyleneglycol concentrations in discrete hypothalamic nuclei reflect the activity of noradrenergic neurons.
    Lookingland KJ; Ireland LM; Gunnet JW; Manzanares J; Tian Y; Moore KE
    Brain Res; 1991 Sep; 559(1):82-8. PubMed ID: 1685939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute effects of sigma ligands on the extracellular DOPAC level in rat frontal cortex and striatum.
    Matsuno K; Matsunaga KH; Mita S
    Neurochem Res; 1995 Feb; 20(2):233-8. PubMed ID: 7783846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in hypothalamic paraventricular nucleus catecholaminergic activity after acute and chronic morphine administration.
    Fuertes G; Milanés MV; Rodríguez-Gago M; Marín MT; Laorden ML
    Eur J Pharmacol; 2000 Jan; 388(1):49-56. PubMed ID: 10657546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Catecholaminergic inhibition by hypercortisolemia in the paraventricular nucleus of conscious rats.
    Pacak K; Palkovits M; Kvetnansky R; Matern P; Hart C; Kopin IJ; Goldstein DS
    Endocrinology; 1995 Nov; 136(11):4814-9. PubMed ID: 7588211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adrenalectomy augments in vivo release of norepinephrine in the paraventricular nucleus during immobilization stress.
    Pacák K; Kvetnanský R; Palkovits M; Fukuhara K; Yadid G; Kopin IJ; Goldstein DS
    Endocrinology; 1993 Sep; 133(3):1404-10. PubMed ID: 8396018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of the paraventricular (PVN) and arcuate (ARC) nuclei of the hypothalamus in the central noradrenergic regulation of liver cytochrome P450.
    Bromek E; Wójcikowski J; Daniel WA
    Biochem Pharmacol; 2013 Dec; 86(11):1614-20. PubMed ID: 24051135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of sigma ligands on the ability of rimcazole to inhibit PCP hsp70 induction.
    Sharp JW; Williams DS
    Brain Res Bull; 1996; 39(6):359-66. PubMed ID: 9138745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Centrally applied nitric oxide donor elevates plasma corticosterone by activation of the hypothalamic noradrenergic neurons in rats.
    Okada S; Murakami Y; Yokotani K
    Brain Res; 2002 Jun; 939(1-2):26-33. PubMed ID: 12020848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of the A10 mesolimbic system by the sigma-receptor agonist (+)SKF 10,047 can be blocked by rimcazole, a novel putative antipsychotic.
    Ceci A; Smith M; French ED
    Eur J Pharmacol; 1988 Sep; 154(1):53-7. PubMed ID: 2903063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roles of paraventricular catecholamines in feeding-associated corticosterone rhythm in rats.
    Honma K; Noe Y; Honma S; Katsuno Y; Hiroshige T
    Am J Physiol; 1992 Jun; 262(6 Pt 1):E948-55. PubMed ID: 1616028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin II evokes noradrenaline release from the paraventricular nucleus in conscious rats.
    Stadler T; Veltmar A; Qadri F; Unger T
    Brain Res; 1992 Jan; 569(1):117-22. PubMed ID: 1611472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of ventral noradrenergic bundle lesions on increased IL-1 in the PVN and hormonal responses to stress in male sprague dawley rats.
    Blandino P; Hueston CM; Barnum CJ; Bishop C; Deak T
    Endocrinology; 2013 Jul; 154(7):2489-500. PubMed ID: 23671261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in catecholaminergic pathways innervating paraventricular nucleus and pituitary-adrenal axis response during morphine dependence: implication of alpha(1)- and alpha(2)-adrenoceptors.
    Laorden ML; Fuertes G; González-Cuello A; Milanés MV
    J Pharmacol Exp Ther; 2000 May; 293(2):578-84. PubMed ID: 10773031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contribution of noradrenergic neurons to 3,4-dihydroxyphenylacetic acid concentrations in the regions of the rat brain containing incertohypothalamic dopaminergic neurons.
    Tian Y; Lookingland KJ; Moore KE
    Brain Res; 1991 Jul; 555(1):135-40. PubMed ID: 1681993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurochemical evidence that 5-hydroxytryptaminergic neurons tonically inhibit noradrenergic neurons terminating in the hypothalamus.
    Tian Y; Eaton MJ; Goudreau JL; Lookingland KJ; Moore KE
    Brain Res; 1993 Apr; 607(1-2):215-21. PubMed ID: 8481797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of noradrenergic neurons projecting to the diencephalon following central administration of histamine is mediated by H1 receptors.
    Fleckenstein AE; Lookingland KJ; Moore KE
    Brain Res; 1994 Feb; 638(1-2):243-7. PubMed ID: 7911061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrophysiological effects of selective sigma-receptor agonists, antagonists, and the selective phencyclidine receptor agonist MK-801 on midbrain dopamine neurons.
    Steinfels GF; Tam SW; Cook L
    Neuropsychopharmacology; 1989 Sep; 2(3):201-8. PubMed ID: 2571340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.